{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:40:09Z","timestamp":1749505209584,"version":"3.41.0"},"reference-count":55,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"23","license":[{"start":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T00:00:00Z","timestamp":1749168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,6]]},"abstract":"<jats:p>The plasma lipidome has been found to be closely related to inflammation, obesity, aging, and other diseases, including various cancers. However, the causal relationship between specific plasma lipid species and the risk of urological cancers remains unclear. This study aimed to investigate the causal relationship between 179 lipid species and 3 common types of urological cancers using a two-sample Mendelian randomization (MR) approach. Large-scale genome-wide association study datasets of 179 lipid species were analyzed to evaluate the association between the plasma lipidome and urological cancers, including bladder cancer, kidney cancer, and prostate cancer. The inverse variance weighted method was employed as the primary analysis approach, supplemented by MR-Egger regression, weighted median, weighted mode, and simple mode methods to ensure the reliability of the findings. Sensitivity analyses, including Cochran <jats:italic toggle=\"yes\">Q<\/jats:italic> test, MR-Egger intercept test, MR Pleiotropy Residual Sum And Outlier, and leave-one-out analysis, were performed to assess the stability and robustness of the causal relationship. The inverse variance weighted analysis showed that higher levels of sterol ester (SE) (27:1\/16:0) and other plasma lipidome were causally associated with increased bladder cancer risk. Similarly, elevated levels of phosphatidylcholine (16:0_22:6) and others were linked to increased kidney cancer risk. For prostate cancer, higher levels of SE (27:1\/17:0) and others were associated with increased risk, while higher levels of SE (27:1\/18:2) and others were associated with decreased risk. The study provides strong evidence for the causal relationships between plasma lipidome and bladder, kidney, and prostate cancers. These findings illuminate complex lipid metabolism pathways in urinary system cancer etiology and highlight specific lipid structures\u2019 differential impact on cancer risk. This research lays a foundation for further exploring biological mechanisms and developing early screening tools and targeted therapies for urological cancers.<\/jats:p>","DOI":"10.1097\/md.0000000000042577","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:02:50Z","timestamp":1749502970000},"page":"e42577","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal relationship between the plasma lipidome and urological cancers: A two-sample Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Rong","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Graduate, Hebei North University, Zhangjiakou, Hebei Province, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liujie","family":"He","sequence":"additional","affiliation":[{"name":"Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyao","family":"Huang","sequence":"additional","affiliation":[{"name":"Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[{"name":"Naval Medical University, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7603-6646","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Graduate, Hebei North University, Zhangjiakou, Hebei Province, China"},{"name":"Department of Urology, Peking University People\u2019s Hospital, Beijing, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250609","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ).","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"R2-20250609","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"R3-20250609","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.annonc.2024.05.537","article-title":"Renal cell carcinoma: ESMO clinical practice guideline for diagnosis, treatment and follow-up.","volume":"35","author":"Powles","year":"2024","journal-title":"Ann Oncol"},{"key":"R4-20250609","doi-asserted-by":"crossref","first-page":"811044","DOI":"10.3389\/fpubh.2022.811044","article-title":"Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019.","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"key":"R5-20250609","doi-asserted-by":"crossref","first-page":"20322","DOI":"10.1038\/s41598-021-99586-1","article-title":"Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls.","volume":"11","author":"Wolrab","year":"2021","journal-title":"Sci Rep"},{"key":"R6-20250609","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/j.cmet.2022.09.023","article-title":"The role of lipids in cancer progression and metastasis.","volume":"34","author":"Martin-Perez","year":"2022","journal-title":"Cell Metab"},{"key":"R7-20250609","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4196\/kjpp.2024.28.3.219","article-title":"Novel artesunate-metformin conjugate inhibits bladder cancer cell growth associated with clusterin\/SREBP1\/FASN signaling pathway.","volume":"28","author":"Lin","year":"2024","journal-title":"Korean J Physiol Pharmacol"},{"key":"R8-20250609","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1158\/2159-8290.CD-21-0211","article-title":"Cholesterol auxotrophy as a targetable vulnerability in clear cell renal cell carcinoma.","volume":"11","author":"Riscal","year":"2021","journal-title":"Cancer Discov"},{"key":"R9-20250609","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1038\/s41418-023-01223-z","article-title":"CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA.","volume":"30","author":"Zhang","year":"2023","journal-title":"Cell Death Differ"},{"key":"R10-20250609","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.tibs.2016.08.010","article-title":"Lipidomics: techniques, applications, and outcomes related to biomedical sciences.","volume":"41","author":"Yang","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"R11-20250609","doi-asserted-by":"crossref","first-page":"e2200568","DOI":"10.1002\/mnfr.202200568","article-title":"Are phosphatidylcholine and lysophosphatidylcholine body levels potentially reliable biomarkers in obesity? A review of human studies.","volume":"67","author":"Bellot","year":"2023","journal-title":"Mol Nutr Food Res"},{"key":"R12-20250609","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrendo.2016.98","article-title":"Lipidomics for studying metabolism.","volume":"12","author":"Han","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"R13-20250609","doi-asserted-by":"crossref","first-page":"6934","DOI":"10.1038\/s41467-023-42532-8","article-title":"Genome-wide association analysis of plasma lipidome identifies 495 genetic associations.","volume":"14","author":"Ottensmann","year":"2023","journal-title":"Nat Commun"},{"key":"R14-20250609","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/med.21868","article-title":"Lipidomic landscape in cancer: actionable insights for membrane-based therapy and diagnoses.","volume":"42","author":"Agarwala","year":"2022","journal-title":"Med Res Rev"},{"key":"R15-20250609","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness.","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab"},{"key":"R16-20250609","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3390\/cancers13092000","article-title":"Lipidomics as a diagnostic tool for prostate cancer.","volume":"13","author":"Buszewska-Forajta","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R17-20250609","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1111\/cas.15935","article-title":"Discovery of lipid profiles in plasma-derived extracellular vesicles as biomarkers for breast cancer diagnosis.","volume":"114","author":"Liu","year":"2023","journal-title":"Cancer Sci"},{"key":"R18-20250609","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41431-022-01038-5","article-title":"Understanding the assumptions underlying Mendelian randomization.","volume":"30","author":"de Leeuw","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"R19-20250609","doi-asserted-by":"crossref","first-page":"a040501","DOI":"10.1101\/cshperspect.a040501","article-title":"Mendelian randomization: concepts and scope.","volume":"12","author":"Richmond","year":"2022","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R20-20250609","doi-asserted-by":"crossref","first-page":"1436955","DOI":"10.3389\/fonc.2024.1436955","article-title":"The effect of lipidomes on the risk of endometrioid endometrial cancer: a Mendelian randomization study.","volume":"14","author":"Lou","year":"2024","journal-title":"Front Oncol"},{"key":"R21-20250609","doi-asserted-by":"crossref","first-page":"1354528","DOI":"10.3389\/fendo.2024.1354528","article-title":"Causal relationship between Alzheimer\u2019s disease and prostate cancer: a bidirectional Mendelian randomization analysis.","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol"},{"key":"R22-20250609","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1177\/0962280215597579","article-title":"A review of instrumental variable estimators for Mendelian randomization.","volume":"26","author":"Burgess","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"R23-20250609","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.csbj.2022.05.015","article-title":"Statistical methods for Mendelian randomization in genome-wide association studies: a review.","volume":"20","author":"Boehm","year":"2022","journal-title":"Comput Struct Biotechnol J"},{"key":"R24-20250609","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12944-024-02103-2","article-title":"The impact of lipidome on breast cancer: a Mendelian randomization study.","volume":"23","author":"Cao","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R25-20250609","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression.","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"R26-20250609","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator.","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"R27-20250609","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R28-20250609","doi-asserted-by":"crossref","first-page":"e20201606","DOI":"10.1084\/jem.20201606","article-title":"Lipid metabolism and cancer.","volume":"218","author":"Bian","year":"2021","journal-title":"J Exp Med"},{"key":"R29-20250609","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/s41467-024-46927-z","article-title":"Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers.","volume":"15","author":"Went","year":"2024","journal-title":"Nat Commun"},{"key":"R30-20250609","first-page":"10","article-title":"Plasma lipids, tumor parameters and survival in HCC patients with HBV and HCV.","volume":"7","author":"Akkiz","year":"2021","journal-title":"J Transl Sci"},{"key":"R31-20250609","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41581-022-00654-0","article-title":"The gut microbiome and hypertension.","volume":"19","author":"O\u2019Donnell","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"R32-20250609","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1111\/cas.12221","article-title":"Accumulated phosphatidylcholine (16:0\/16:1) in human colorectal cancer; possible involvement of LPCAT4.","volume":"104","author":"Kurabe","year":"2013","journal-title":"Cancer Sci"},{"key":"R33-20250609","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jcb.10659","article-title":"Choline phospholipid metabolism: a target in cancer cells?","volume":"90","author":"Ackerstaff","year":"2003","journal-title":"J Cell Biochem"},{"key":"R34-20250609","doi-asserted-by":"crossref","first-page":"e4112","DOI":"10.1002\/nbm.4112","article-title":"Focus on the glycerophosphocholine pathway in choline phospholipid metabolism of cancer.","volume":"32","author":"Sonkar","year":"2019","journal-title":"NMR Biomed"},{"key":"R35-20250609","doi-asserted-by":"crossref","first-page":"768606","DOI":"10.3389\/fimmu.2022.768606","article-title":"Phosphatidylcholine-derived lipid mediators: the crosstalk between cancer cells and immune cells.","volume":"13","author":"Saito","year":"2022","journal-title":"Front Immunol"},{"key":"R36-20250609","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.3390\/ijms20092167","article-title":"Membrane lipid composition: effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues.","volume":"20","author":"Casares","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R37-20250609","doi-asserted-by":"crossref","first-page":"5266","DOI":"10.3390\/ijms23095266","article-title":"Bilayer forming phospholipids as targets for cancer therapy.","volume":"23","author":"Stoica","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R38-20250609","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3389\/fonc.2016.00266","article-title":"Targeting phospholipid metabolism in cancer.","volume":"6","author":"Cheng","year":"2016","journal-title":"Front Oncol"},{"key":"R39-20250609","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1002\/cam4.4699","article-title":"Understanding modulations of lipid mediators in cancer using a murine model of carcinomatous peritonitis.","volume":"11","author":"Kurano","year":"2022","journal-title":"Cancer Med"},{"key":"R40-20250609","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/bph.15737","article-title":"N-Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth.","volume":"179","author":"Romano","year":"2022","journal-title":"Br J Pharmacol"},{"key":"R41-20250609","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4062\/biomolther.2013.110","article-title":"Action and signaling of lysophosphatidylethanolamine in MDA-MB-231 breast cancer cells.","volume":"22","author":"Park","year":"2014","journal-title":"Biomol Ther (Seoul)"},{"key":"R42-20250609","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.1016\/j.febslet.2007.08.014","article-title":"Lysophosphatidylethanolamine stimulates chemotactic migration and cellular invasion in SK-OV3 human ovarian cancer cells: involvement of pertussis toxin-sensitive G-protein coupled receptor.","volume":"581","author":"Park","year":"2007","journal-title":"FEBS Lett"},{"key":"R43-20250609","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s11745-002-0978-z","article-title":"Anandamide and other N-acylethanolamines in human tumors.","volume":"37","author":"Schmid","year":"2002","journal-title":"Lipids"},{"key":"R44-20250609","first-page":"221","article-title":"Adipose triglyceride lipase regulation: an overview.","volume":"19","author":"Cerk","year":"2018","journal-title":"Curr Protein Pept Sci"},{"key":"R45-20250609","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/ijms24010012","article-title":"Overview of cancer metabolism and signaling transduction.","volume":"24","author":"Chae","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R46-20250609","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/abbs\/gmab144","article-title":"Epicatechin gallate prevents the de novo synthesis of fatty acid and the migration of prostate cancer cells.","volume":"53","author":"Chen","year":"2021","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"R47-20250609","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.3390\/ijms22115793","article-title":"A comprehensive review: sphingolipid metabolism and implications of disruption in sphingolipid homeostasis.","volume":"22","author":"Quinville","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R48-20250609","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrc.2017.96","article-title":"Sphingolipid metabolism in cancer signalling and therapy.","volume":"18","author":"Ogretmen","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"R49-20250609","doi-asserted-by":"crossref","first-page":"101043","DOI":"10.1016\/j.tranon.2021.101043","article-title":"Influence of cholesterol on cancer progression and therapy.","volume":"14","author":"Mayengbam","year":"2021","journal-title":"Transl Oncol"},{"key":"R50-20250609","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.3390\/cancers13184696","article-title":"Prostate cancer-focus on cholesterol.","volume":"13","author":"Skara","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R51-20250609","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.it.2021.11.007","article-title":"The cholesterol pathway: impact on immunity and cancer.","volume":"43","author":"King","year":"2022","journal-title":"Trends Immunol"},{"key":"R52-20250609","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3390\/cells12101411","article-title":"A plethora of functions condensed into tiny phospholipids: the story of PI4P and PI(4,5)P(2).","volume":"12","author":"Bura","year":"2023","journal-title":"Cells"},{"issue":"Pt 17","key":"R53-20250609","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1113\/jphysiol.2010.192153","article-title":"Phosphoinositides: lipid regulators of membrane proteins.","volume":"588","author":"Falkenburger","year":"2010","journal-title":"J Physiol"},{"key":"R54-20250609","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc2842","article-title":"Phosphoinositide signalling in cancer: beyond PI3K and PTEN.","volume":"10","author":"Bunney","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"R55-20250609","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41580-018-0015-0","article-title":"The functions and regulation of the PTEN tumour suppressor: new modes and prospects.","volume":"19","author":"Lee","year":"2018","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042577","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T21:02:58Z","timestamp":1749502978000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,6]]},"references-count":55,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042577","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,6]]}}}